RecruitingNot ApplicableNCT05387863

Decision Aid (DA) for Renal Patients

Evaluation of a Decision Aid in the Treatment Planning of Small Renal Tumors


Sponsor

NYU Langone Health

Enrollment

40 participants

Start Date

Sep 12, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a patient decision-support tool can help people with a small kidney tumor make more informed choices about their treatment options — which may include surgery, ablation (using heat or cold to destroy the tumor), or active surveillance (watchful waiting without immediate treatment). **You may be eligible if...** - You are 18 or older - You have been diagnosed with a localized kidney tumor that is 4 cm or smaller in size - You are scheduled for a standard clinical visit to discuss your treatment options - You are either already scheduled for a procedure or still in the decision-making phase **You may NOT be eligible if...** - You have stage IV cancer of any type - You are unable to provide informed consent - You are considered a vulnerable subject as defined by the study team Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDecision Aid (DA) Web Tool

The DA web tool provides information on kidney masses and available treatment options. It uses risk communication, directed teaching, and interactive benefit-harm assessment to present information.

OTHERInstitutional Pamphlet

The institutional pamphlet provides information on kidney masses, but does not use risk communication, directed teaching, or interactive benefit-harm assessment.


Locations(1)

NYU Langone Health

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05387863


Related Trials